Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Revenue
Dexcom Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Revenue
$3.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
29%
|
CAGR 10-Years
37%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
Dexcom Inc
Revenue Breakdown
Breakdown by Geography
Dexcom Inc
Total Revenue:
3.6B
USD
|
United States:
2.6B
USD
|
International:
997m
USD
|
Breakdown by Segments
Dexcom Inc
See Also
What is Dexcom Inc's Revenue?
Revenue
3.6B
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Revenue amounts to 3.6B USD.
What is Dexcom Inc's Revenue growth rate?
Revenue CAGR 10Y
37%
Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for Dexcom Inc have been 23% over the past three years , 29% over the past five years , and 37% over the past ten years .